A primary challenge lies in delineating the precise mechanisms underlying aberrant GSDME activation in HCC cells, particularly the role of epigenetic modifications that are fundamental to understanding its promotion of HCC. This evidence concerns the gene GSDME and hepatocellular carcinoma.